Table of Contents Author Guidelines Submit a Manuscript
AIDS Research and Treatment
Volume 2014, Article ID 235483, 5 pages
http://dx.doi.org/10.1155/2014/235483
Research Article

Resource Utilization and Costs of Care prior to ART Initiation for Pediatric Patients in Zambia

1Zambia Center for Applied Health Research and Development, 10100 Lusaka, Zambia
2Center for Global Health and Development, Boston University, Boston, MA 02118, USA
3Health Economics and Epidemiology Research Office, Wits Health Consortium, Department of Clinical Medicine, School of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2198, South Africa
4Zambian Ministry of Health, 10100 Lusaka, Zambia
5Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27514, USA
6Centre for Infectious Disease Research in Zambia, 101000 Lusaka, Zambia
7Department of International Health, School of Public Health, Boston University, Boston, MA 02118, USA

Received 14 December 2013; Accepted 6 February 2014; Published 10 March 2014

Academic Editor: Robert R. Redfield

Copyright © 2014 Hari S. Iyer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Government of the Republic of Zambia, Ministry of Health and the National AIDS Council, “Zambia country report: Monitoring the declaration of commitment on HIV and AIDS and the universal access,” Biennial Report, 2012, http://www.unaids.org/en/dataanalysis/knowyourresponse/countryprogressreports/2012countries/ce_ZM_Narrative_Report.pdf. View at Google Scholar
  2. UNAIDS, “Zambia HIV and AIDS estimates,” 2011, http://www.unaids.org/en/regionscountries/countries/zambia/.
  3. World Health Organization, “Global HIV/AIDS response: epidemic update and health sector progress towards universal access: progress report,” 2011, http://whqlibdoc.who.int/publications/2011/9789241502986_eng.pdf.
  4. J. Orne-Gliemann, R. Becquet, D. K. Ekouevi, V. Leroy, F. Perez, and F. Dabis, “Children and HIV/AIDS: from research to policy and action in resource-limited settings,” AIDS, vol. 22, no. 7, pp. 797–805, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Rosen and M. P. Fox, “Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review,” PLoS Medicine, vol. 8, no. 7, Article ID e1001056, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. M.-F. Anaky, J. Duvignac, L. Wemin et al., “Scaling up antiretroviral therapy for HIV-infected children in Côte d'Ivoire: determinants of survival and loss to programme,” Bulletin of the World Health Organization, vol. 88, no. 7, pp. 490–500, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. M.-E. Raguenaud, P. Isaakidis, R. Zachariah et al., “Excellent outcomes among HIV+ children on ART, but unacceptably high pre-ART mortality and losses to follow-up: a cohort study from Cambodia,” BMC Pediatrics, vol. 9, article 54, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. C. A. Scott, H. Iyer, D. Lembela Bwalya et al., “Retention in care and outpatient costs for children receiving antiretroviral therapy in Zambia: a retrospective cohort analysis,” PLoS ONE, vol. 8, Article ID e67910, 2013. View at Google Scholar
  9. Government of the Republic of Zambia, Ministry of Health, “Zambian guidelines for antiretroviral therapy of HIV infection in infants and children: towards universal access,” 2007, http://www.who.int/hiv/amds/zambia_paediatric_guidelines_2007.pdf.
  10. M. C. Weinstein, J. E. Siegel, M. R. Gold, M. S. Kamlet, and L. B. Russell, “Recommendations of the panel on cost-effectiveness in health and medicine,” Journal of the American Medical Association, vol. 276, no. 15, pp. 1253–1258, 1996. View at Publisher · View at Google Scholar · View at Scopus
  11. M. S. Limited, Medical Stores Limited: 2010 Catalogue, Government of the Republic of Zambia, Ministry of Health, Lusaka, Zambia, 2010.
  12. C. Bolton-Moore, M. Mubiana-Mbewe, R. A. Cantrell et al., “Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia,” Journal of the American Medical Association, vol. 298, no. 16, pp. 1888–1899, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. A. S. Walker, V. Mulenga, F. Sinyinza et al., “Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP trial,” Journal of Acquired Immune Deficiency Syndromes, vol. 42, no. 5, pp. 637–645, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Desmonde, P. Coffie, E. Aka et al., “Severe morbidity and mortality in untreated HIV-infected children in a paediatric care programme in Abidjan, Côte d'Ivoire, 2004–2009,” BMC Infectious Diseases, vol. 11, article 182, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. J. H. Bratt, K. Torpey, M. Kabaso, and Y. Gondwe, “Costs of HIV/AIDS outpatient services delivered through Zambian public health facilities,” Tropical Medicine and International Health, vol. 16, no. 1, pp. 110–118, 2011. View at Publisher · View at Google Scholar · View at Scopus